药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Spectinomycin
N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine
The risk or severity of adverse effects can be increased when Midomafetamine is combined with N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine.
Spectinomycin
2,5-Dimethoxy-4-ethylthioamphetamine
The risk or severity of adverse effects can be increased when Midomafetamine is combined with 2,5-Dimethoxy-4-ethylthioamphetamine.
Spectinomycin
Lormetazepam
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Lormetazepam.
Spectinomycin
Doxefazepam
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Doxefazepam.
Spectinomycin
Carbromal
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Carbromal.
Spectinomycin
Reposal
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Reposal.
Spectinomycin
Ethadione
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Ethadione.
Spectinomycin
Vinylbital
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Vinylbital.
Spectinomycin
Mephenoxalone
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Mephenoxalone.
Spectinomycin
Fazadinium bromide
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Fazadinium bromide.
Spectinomycin
Cyclobarbital
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Cyclobarbital.
Spectinomycin
Methylpentynol
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Methylpentynol.
Spectinomycin
Vinyl ether
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Vinyl ether.
Spectinomycin
Niaprazine
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Niaprazine.
Spectinomycin
Hexapropymate
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Hexapropymate.
Spectinomycin
Alcuronium
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Alcuronium.
Spectinomycin
Pridinol
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Pridinol.
Spectinomycin
Fabomotizole
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Fabomotizole.
Spectinomycin
Diethyl ether
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Diethyl ether.
Spectinomycin
Naftidrofuryl
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Naftidrofuryl.